DTx Pharma picks up $100m Series B
DTx Pharma Inc, a biotechnology company, has raised $100 million in Series B financing.
DTx Pharma Inc, a biotechnology company, has raised $100 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination